A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Public ClinicalTrials.gov record NCT03261960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03261960
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Braintree Laboratories
- Industry
- Enrollment
- 389 participants
Conditions and interventions
Conditions
Interventions
- BLI4700 Drug
- Magnesium bowel preparation Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2017
- Primary completion
- Mar 25, 2018
- Completion
- Mar 25, 2018
- Last update posted
- Sep 7, 2021
2017 – 2018
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Braintree Research Site 119 | Dothan | Alabama | 36305 | — |
| Braintree Research Site 117 | Tucson | Arizona | 85710 | — |
| Braintree Research Site 108 | Little Rock | Arkansas | 72117 | — |
| Braintree Research Site 110 | Little Rock | Arkansas | 72211 | — |
| Braintree Research Site 139 | Palmetto Bay | Florida | 33157 | — |
| Braintree Research Site 124 | Oak Lawn | Illinois | 60453 | — |
| Braintree Research Site 134 | Indianapolis | Indiana | 46202 | — |
| Braintree Research Site 112 | Chevy Chase | Maryland | 20815 | — |
| Braintree Research Site 141 | Towson | Maryland | 20214 | — |
| Braintree Research Site 125 | Chesterfield | Missouri | 48047 | — |
| Braintree Research Site 102 | St Louis | Missouri | 63128 | — |
| Braintree Research Site 145 | Egg Harbor | New Jersey | 08234 | — |
| Braintree Research Site 114 | Poughkeepsie | New York | 12601 | — |
| Braintree Research Site 105 | Asheville | North Carolina | 28801 | — |
| Braintree Research Site 115 | Charlotte | North Carolina | 28207 | — |
| Braintree Research Site 137 | Raleigh | North Carolina | 27607 | — |
| Braintree Research Site 101 | Raleigh | North Carolina | 27612 | — |
| Braintree Research Site 107 | Greenville | South Carolina | 29615 | — |
| Braintree Research Site 131 | Charlottesville | Virginia | 22911 | — |
| Braintree Research Site 121 | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03261960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 7, 2021 · Synced Jun 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03261960 live on ClinicalTrials.gov.